NCT03473548View on ClinicalTrials.gov

Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 28, 2017

Primary Completion Date

October 14, 2019

Study Completion Date

October 14, 2019

Conditions
Sleep Apnea, Obstructive
Interventions
DEVICE

Portable sleep monitor

Type III at home portable monitor obtaining greater than or equal to 6 hours of data adequate for polysomnography analysis

OTHER

In-laboratory Polysomnography

Polysomnography testing will determine the sleep stages, apnea hypopnea index (AHI), blood saturation oxygen nadir (SPO2 nadir), and average blood oxygen saturation. A McGill Oximetry Score will also be calculated for the in-laboratory PSG.

Trial Locations (1)

63110

St. Louis Children's Hospital, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03473548 - Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients | Biotech Hunter | Biotech Hunter